These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38556452)

  • 1. Peritoneal carcinomatosis in mouse models.
    Arrizabalaga L; Di Trani CA; Risson A; Belsúe V; Gomar C; Ardaiz N; Berrondo P; Aranda F; Bella Á
    Methods Cell Biol; 2024; 185():67-78. PubMed ID: 38556452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
    Colombo PE; Boustta M; Poujol S; Jarlier M; Bressolle F; Teulon I; Ladjemi MZ; Pinguet F; Rouanet P; Vert M
    Gynecol Oncol; 2011 Sep; 122(3):632-40. PubMed ID: 21665252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis.
    Bella Á; Arrizabalaga L; Di Trani CA; Gonzalez-Gomariz J; Gomar C; Russo-Cabrera JS; Olivera I; Cirella A; Fernandez-Sendin M; Alvarez M; Teijeira A; Atay C; Medina-Echeverz J; Hinterberger M; Hochrein H; Melero I; Berraondo P; Aranda F
    J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37918917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.
    Li PC; Chen LD; Zheng F; Li Y
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis.
    Ridwelski K; Meyer F; Hribaschek A; Kasper U; Lippert H
    J Surg Oncol; 2002 Jan; 79(1):10-6. PubMed ID: 11754372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer.
    Mei LJ; Yang XJ; Tang L; Hassan AH; Yonemura Y; Li Y
    BMC Cancer; 2010 Apr; 10():124. PubMed ID: 20359350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis.
    Tseng SH; Park ST; Lam B; Tsai YC; Cheng MA; Farmer E; Xing D; Hung CF
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32111730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted intraabdominal chemotherapy for peritoneal carcinomatosis.
    Samel S; Löhr M
    Cancer Treat Res; 2007; 134():469-82. PubMed ID: 17633075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications.
    Bella Á; Di Trani CA; Fernández-Sendin M; Arrizabalaga L; Cirella A; Teijeira Á; Medina-Echeverz J; Melero I; Berraondo P; Aranda F
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33669017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.
    Hunt H; Simón-Gracia L; Tobi A; Kotamraju VR; Sharma S; Nigul M; Sugahara KN; Ruoslahti E; Teesalu T
    J Control Release; 2017 Aug; 260():142-153. PubMed ID: 28603028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging.
    Taibi A; Albouys J; Jacques J; Perrin ML; Yardin C; Durand Fontanier S; Bardet SM
    PLoS One; 2019; 14(7):e0220360. PubMed ID: 31365553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 13. Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats.
    Lopes Cardozo AM; Gupta A; Koppe MJ; Meijer S; van Leeuwen PA; Beelen RJ; Bleichrodt RP
    Eur J Surg Oncol; 2001 Jun; 27(4):359-63. PubMed ID: 11417980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer.
    Kasai S; Kuwayama N; Motoo Y; Kawashima A; Matsumoto K; Yano S; Matsushima K; Yasumoto K
    Biochem Biophys Res Commun; 2022 Apr; 600():80-86. PubMed ID: 35196631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
    Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs.
    Montagner IM; Merlo A; Zuccolotto G; Renier D; Campisi M; Pasut G; Zanovello P; Rosato A
    PLoS One; 2014; 9(11):e112240. PubMed ID: 25383653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
    Pestieau SR; Sugarbaker PH
    Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats.
    Otto J; Jansen PL; Lucas S; Schumpelick V; Jansen M
    BMC Cancer; 2007 Jun; 7():104. PubMed ID: 17584925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
    Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
    Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.